1. Home
  2. CHEK vs ICCT Comparison

CHEK vs ICCT Comparison

Compare CHEK & ICCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEK
  • ICCT
  • Stock Information
  • Founded
  • CHEK 2004
  • ICCT 1992
  • Country
  • CHEK Israel
  • ICCT United States
  • Employees
  • CHEK N/A
  • ICCT N/A
  • Industry
  • CHEK Medical Electronics
  • ICCT Computer Software: Prepackaged Software
  • Sector
  • CHEK Health Care
  • ICCT Technology
  • Exchange
  • CHEK Nasdaq
  • ICCT Nasdaq
  • Market Cap
  • CHEK 5.1M
  • ICCT 5.2M
  • IPO Year
  • CHEK 2015
  • ICCT N/A
  • Fundamental
  • Price
  • CHEK $0.80
  • ICCT $0.16
  • Analyst Decision
  • CHEK
  • ICCT
  • Analyst Count
  • CHEK 0
  • ICCT 0
  • Target Price
  • CHEK N/A
  • ICCT N/A
  • AVG Volume (30 Days)
  • CHEK 29.4K
  • ICCT 5.9M
  • Earning Date
  • CHEK 11-25-2024
  • ICCT 11-29-2024
  • Dividend Yield
  • CHEK N/A
  • ICCT N/A
  • EPS Growth
  • CHEK N/A
  • ICCT N/A
  • EPS
  • CHEK N/A
  • ICCT N/A
  • Revenue
  • CHEK N/A
  • ICCT $10,266,331.00
  • Revenue This Year
  • CHEK N/A
  • ICCT N/A
  • Revenue Next Year
  • CHEK N/A
  • ICCT N/A
  • P/E Ratio
  • CHEK N/A
  • ICCT N/A
  • Revenue Growth
  • CHEK N/A
  • ICCT 34.56
  • 52 Week Low
  • CHEK $0.76
  • ICCT $0.15
  • 52 Week High
  • CHEK $3.62
  • ICCT $3.20
  • Technical
  • Relative Strength Index (RSI)
  • CHEK 21.50
  • ICCT 30.94
  • Support Level
  • CHEK $0.80
  • ICCT $0.17
  • Resistance Level
  • CHEK $1.28
  • ICCT $0.19
  • Average True Range (ATR)
  • CHEK 0.08
  • ICCT 0.04
  • MACD
  • CHEK -0.02
  • ICCT 0.00
  • Stochastic Oscillator
  • CHEK 7.57
  • ICCT 3.55

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About ICCT iCoreConnect Inc. Common stock

iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.

Share on Social Networks: